Latest Insider Transactions at Sea Spine Holdings Corp (SPNE)
This section provides a real-time view of insider transactions for Sea Spine Holdings Corp (SPNE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of SeaSpine Holdings Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of SeaSpine Holdings Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 05
2023
|
John B Henneman Iii Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
82,654
-100.0%
|
-
|
|
Jan 05
2023
|
Michael Fekete Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
111,966
-100.0%
|
-
|
|
Jan 05
2023
|
Renee Gaeta Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
36,056
-100.0%
|
-
|
|
Jan 05
2023
|
Shweta Maniar Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
23,993
-100.0%
|
-
|
|
Jan 05
2023
|
Angela Steinway Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
23,725
-100.0%
|
-
|
|
Jan 05
2023
|
Kirtley C. Stephenson Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
9,700
-100.0%
|
-
|
|
Jan 05
2023
|
Kirtley C. Stephenson Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
128,640
-100.0%
|
-
|
|
Jan 05
2023
|
Keith Valentine Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
333,797
-100.0%
|
-
|
|
Jan 05
2023
|
John J. Bostjancic Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
102,563
-100.0%
|
-
|
|
Jan 05
2023
|
Paul S. Benny VP, Treasurer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
20,950
-100.0%
|
-
|
|
Jan 05
2023
|
Dennis Cirino SVP, Global Spinal Systems |
SELL
Sale (or disposition) back to the issuer
|
Direct |
48,556
-100.0%
|
-
|
|
Jan 05
2023
|
Patrick L Keran SVP, General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
69,628
-100.0%
|
-
|
|
Jan 05
2023
|
Tyler Lipschultz SVP, Orthobiologics and BD |
SELL
Sale (or disposition) back to the issuer
|
Direct |
131,284
-100.0%
|
-
|
|
Jan 05
2023
|
John J. Winge Vice President, Sales |
SELL
Sale (or disposition) back to the issuer
|
Direct |
90,951
-100.0%
|
-
|
|
Jan 05
2023
|
Stuart Essig Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
460,275
-100.0%
|
-
|
|
Jan 05
2023
|
Keith Bradley Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
88,592
-100.0%
|
-
|
|
Jan 01
2023
|
Keith Valentine Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,170
-2.1%
|
$57,360
$8.35 P/Share
|
|
Jan 01
2023
|
Keith Valentine Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,183
+3.45%
|
-
|
|
Jan 01
2023
|
John J. Bostjancic Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,281
-3.1%
|
$26,248
$8.35 P/Share
|
|
Jan 01
2023
|
John J. Bostjancic Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,575
+5.0%
|
-
|
|
Jan 01
2023
|
Paul S. Benny VP, Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
425
-1.99%
|
$3,400
$8.35 P/Share
|
|
Jan 01
2023
|
Paul S. Benny VP, Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,041
+4.64%
|
-
|
|
Jan 01
2023
|
Dennis Cirino SVP, Global Spinal Systems |
SELL
Payment of exercise price or tax liability
|
Direct |
3,150
-6.09%
|
$25,200
$8.35 P/Share
|
|
Jan 01
2023
|
Dennis Cirino SVP, Global Spinal Systems |
BUY
Exercise of conversion of derivative security
|
Direct |
5,352
+9.38%
|
-
|
|
Jan 01
2023
|
Patrick L Keran SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,108
-4.27%
|
$24,864
$8.35 P/Share
|
|
Jan 01
2023
|
Patrick L Keran SVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
5,280
+6.77%
|
-
|
|
Jan 01
2023
|
Tyler Lipschultz SVP, Orthobiologics and BD |
SELL
Payment of exercise price or tax liability
|
Direct |
3,411
-2.53%
|
$27,288
$8.35 P/Share
|
|
Jan 01
2023
|
Tyler Lipschultz SVP, Orthobiologics and BD |
BUY
Exercise of conversion of derivative security
|
Direct |
8,362
+5.85%
|
-
|
|
Jan 01
2023
|
John J. Winge Vice President, Sales |
SELL
Payment of exercise price or tax liability
|
Direct |
2,490
-2.66%
|
$19,920
$8.35 P/Share
|
|
Jan 01
2023
|
John J. Winge Vice President, Sales |
BUY
Exercise of conversion of derivative security
|
Direct |
4,868
+4.95%
|
-
|
|
Dec 29
2022
|
Shweta Maniar Director |
SELL
Open market or private sale
|
Direct |
3,786
-13.63%
|
$30,288
$8.0 P/Share
|
|
Dec 28
2022
|
Tyler Lipschultz SVP, Orthobiologics and BD |
BUY
Other acquisition or disposition
|
Direct |
2,500
+1.94%
|
$10,000
$4.92 P/Share
|
|
Dec 28
2022
|
Paul S. Benny VP, Treasurer |
BUY
Other acquisition or disposition
|
Direct |
1,320
+6.1%
|
$5,280
$4.92 P/Share
|
|
Nov 08
2022
|
Beau Standish President, Enabling Tech |
BUY
Conversion of derivative security
|
Direct |
254,950
+50.0%
|
-
|
|
Jul 14
2022
|
Beau Standish President, Enabling Tech |
SELL
Open market or private sale
|
Direct |
50,000
-100.0%
|
$250,000
$5.73 P/Share
|
|
Jun 30
2022
|
Keith Valentine Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
2,385
+0.72%
|
$9,540
$4.8 P/Share
|
|
Jun 30
2022
|
Paul S. Benny VP, Treasurer |
BUY
Other acquisition or disposition
|
Direct |
1,261
+6.22%
|
$5,044
$4.8 P/Share
|
|
Jun 30
2022
|
Dennis Cirino SVP, Global Spinal Systems |
BUY
Other acquisition or disposition
|
Direct |
2,384
+4.89%
|
$9,536
$4.8 P/Share
|
|
Jun 30
2022
|
John J. Winge Vice President, Sales |
BUY
Other acquisition or disposition
|
Direct |
1,785
+1.98%
|
$7,140
$4.8 P/Share
|
|
Jun 02
2022
|
Keith Bradley Director |
SELL
Payment of exercise price or tax liability
|
Direct |
319
-0.36%
|
$2,233
$7.77 P/Share
|
|
Jun 01
2022
|
Kirtley C. Stephenson Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,321
+14.79%
|
-
|
|
Jun 01
2022
|
Keith Bradley Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,943
+15.21%
|
-
|
|
Jun 01
2022
|
Stuart Essig Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,943
+3.35%
|
-
|
|
Jun 01
2022
|
Michael Fekete Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,596
+9.83%
|
-
|
|
Jun 01
2022
|
Renee Gaeta Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,943
+30.66%
|
-
|
|
Jun 01
2022
|
John B Henneman Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,943
+16.17%
|
-
|
|
Jun 01
2022
|
Shweta Maniar Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,943
+36.46%
|
-
|
|
Jun 01
2022
|
Angela Steinway Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,943
+40.19%
|
-
|
|
Mar 14
2022
|
Renee Gaeta Director |
SELL
Open market or private sale
|
Direct |
2,000
-9.04%
|
$24,000
$12.03 P/Share
|
|
Mar 02
2022
|
Keith Bradley Director |
SELL
Payment of exercise price or tax liability
|
Direct |
37
-0.05%
|
$481
$13.25 P/Share
|